A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation

Introduction: Embolization of the Middle Meningeal Artery (EMMA) is an emerging treatment option for patients with Chronic Subdural Haematoma (CSDH). Questions: (1) Can EMMA change the natural history of untreated minimally symptomatic CSDH which do not require immediate evacuation? (2) What is the...

Full description

Bibliographic Details
Main Authors: Alvaro Rojas-Villabona, Saffwan Mohamed, Oliver Kennion, Rajeev Padmanabhan, Aslam Siddiqui, Manjunath Prasad, Nitin Mukerji
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Brain and Spine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772529423009608
_version_ 1797398896673030144
author Alvaro Rojas-Villabona
Saffwan Mohamed
Oliver Kennion
Rajeev Padmanabhan
Aslam Siddiqui
Manjunath Prasad
Nitin Mukerji
author_facet Alvaro Rojas-Villabona
Saffwan Mohamed
Oliver Kennion
Rajeev Padmanabhan
Aslam Siddiqui
Manjunath Prasad
Nitin Mukerji
author_sort Alvaro Rojas-Villabona
collection DOAJ
description Introduction: Embolization of the Middle Meningeal Artery (EMMA) is an emerging treatment option for patients with Chronic Subdural Haematoma (CSDH). Questions: (1) Can EMMA change the natural history of untreated minimally symptomatic CSDH which do not require immediate evacuation? (2) What is the role of EMMA in the prevention of recurrence following surgical treatment? (3) Can the procedure be performed under local anaesthetic? Material and methods: Systematic literature review. No randomised clinical trials available on EMMA for meta-analysis. Results: Six unique large cohorts with more than 50 embolisations were identified (evidence: 3b-4). EMMA can control the progression of surgically naïve CSDH in 91.1–100% of the patients, in which haematoma expansion is halted, or the lesion decreases and resolves. Treatment failure requiring surgery occurs in 0–4.1% of the patients having EMMA as the primary and only treatment. Treatment failure requiring surgery goes up slightly to 6.8% if post-surgical patients are included. When EMMA is used as postsurgical adjunctive the risk of recurrence is 1.4–8.9% compared to 10–20% in surgical series. EMMA has minimal morbidity and it is feasible under local anaesthesia or slight sedation in the majority of cases. Conclusion: There is cumulative low-quality evidence in the literature that EMMA may be able to modify the natural course of the disease. It appears effective in controlling progression of CSDHs in patients having it as a primary standing alone treatment and it reduces the risk of recurrence and the need for surgical intervention in refractory postsurgical cases or as a postsurgical adjunctive treatment with minimal morbidity (recommendation: C).
first_indexed 2024-03-09T01:33:06Z
format Article
id doaj.art-51048708d7154478ac76c329f28b0ca8
institution Directory Open Access Journal
issn 2772-5294
language English
last_indexed 2024-03-09T01:33:06Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Brain and Spine
spelling doaj.art-51048708d7154478ac76c329f28b0ca82023-12-09T06:09:12ZengElsevierBrain and Spine2772-52942023-01-013102672A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuationAlvaro Rojas-Villabona0Saffwan Mohamed1Oliver Kennion2Rajeev Padmanabhan3Aslam Siddiqui4Manjunath Prasad5Nitin Mukerji6Department of Neurosurgery, James Cook University Hospital, Middlesbrough, UK; Corresponding author. Department of Neurosurgery, James Cook University Hospital, Marton Road, Middlesbrough, YS4 3BW, UK.Department of Neurosurgery, James Cook University Hospital, Middlesbrough, UKDepartment of Neurosurgery, James Cook University Hospital, Middlesbrough, UKDepartment of Neuroradiology, James Cook University Hospital, Middlesbrough, UKDepartment of Neuroradiology, James Cook University Hospital, Middlesbrough, UKDepartment of Neurosurgery, James Cook University Hospital, Middlesbrough, UKDepartment of Neurosurgery, James Cook University Hospital, Middlesbrough, UKIntroduction: Embolization of the Middle Meningeal Artery (EMMA) is an emerging treatment option for patients with Chronic Subdural Haematoma (CSDH). Questions: (1) Can EMMA change the natural history of untreated minimally symptomatic CSDH which do not require immediate evacuation? (2) What is the role of EMMA in the prevention of recurrence following surgical treatment? (3) Can the procedure be performed under local anaesthetic? Material and methods: Systematic literature review. No randomised clinical trials available on EMMA for meta-analysis. Results: Six unique large cohorts with more than 50 embolisations were identified (evidence: 3b-4). EMMA can control the progression of surgically naïve CSDH in 91.1–100% of the patients, in which haematoma expansion is halted, or the lesion decreases and resolves. Treatment failure requiring surgery occurs in 0–4.1% of the patients having EMMA as the primary and only treatment. Treatment failure requiring surgery goes up slightly to 6.8% if post-surgical patients are included. When EMMA is used as postsurgical adjunctive the risk of recurrence is 1.4–8.9% compared to 10–20% in surgical series. EMMA has minimal morbidity and it is feasible under local anaesthesia or slight sedation in the majority of cases. Conclusion: There is cumulative low-quality evidence in the literature that EMMA may be able to modify the natural course of the disease. It appears effective in controlling progression of CSDHs in patients having it as a primary standing alone treatment and it reduces the risk of recurrence and the need for surgical intervention in refractory postsurgical cases or as a postsurgical adjunctive treatment with minimal morbidity (recommendation: C).http://www.sciencedirect.com/science/article/pii/S2772529423009608Middle meningeal arteryEmbolizationTherapeuticChronic subdural haematoma
spellingShingle Alvaro Rojas-Villabona
Saffwan Mohamed
Oliver Kennion
Rajeev Padmanabhan
Aslam Siddiqui
Manjunath Prasad
Nitin Mukerji
A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation
Brain and Spine
Middle meningeal artery
Embolization
Therapeutic
Chronic subdural haematoma
title A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation
title_full A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation
title_fullStr A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation
title_full_unstemmed A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation
title_short A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation
title_sort systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation
topic Middle meningeal artery
Embolization
Therapeutic
Chronic subdural haematoma
url http://www.sciencedirect.com/science/article/pii/S2772529423009608
work_keys_str_mv AT alvarorojasvillabona asystematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT saffwanmohamed asystematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT oliverkennion asystematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT rajeevpadmanabhan asystematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT aslamsiddiqui asystematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT manjunathprasad asystematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT nitinmukerji asystematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT alvarorojasvillabona systematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT saffwanmohamed systematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT oliverkennion systematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT rajeevpadmanabhan systematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT aslamsiddiqui systematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT manjunathprasad systematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation
AT nitinmukerji systematicreviewofmiddlemeningealarteryembolizationforminimallysymptomaticchronicsubduralhaematomasthatdonotrequireimmediateevacuation